- ICPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $211.0 million.
- ICPT has traded 537,548 shares today.
- ICPT is up 3.2% today.
- ICPT was down 16.1% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICPT with the Ticky from Trade-Ideas. See the FREE profile for ICPT NOW at Trade-Ideas More details on ICPT: Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. Currently there are 8 analysts that rate Intercept Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold. The average volume for Intercept Pharmaceuticals has been 611,500 shares per day over the past 30 days. Intercept has a market cap of $7.6 billion and is part of the health care sector and drugs industry. The stock has a beta of -9.00 and a short float of 19.6% with 3.29 days to cover. Shares are up 68.9% year-to-date as of the close of trading on Tuesday.